ADENOCARCINOMA OF LUNG
Clinical trials for ADENOCARCINOMA OF LUNG explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF LUNG trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CRISPR lung cancer trial pulled before it even started
Disease control TerminatedThis trial aimed to test a new treatment for people with metastatic non-small cell lung cancer. Doctors would take immune cells from a patient's tumor, use CRISPR gene editing to make them stronger, and then put them back into the patient. The goal was to see if these edited cell…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated May 17, 2026 04:41 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a new drug called PF-07220060 in people with advanced solid tumors, including breast, prostate, lung, and liposarcoma cancers. The drug is given alone or with hormone therapies to see if it is safe and works well. About 362 participants will take part to find the…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 13, 2026 16:00 UTC